Genenta Science S.p.A. (SAEN)

NASDAQ: SAEN · Real-Time Price · USD

0.6240

-0.0560 (-8.24%)

At close: Nov 12, 2026, 4:00 PM EST

0.6241

+0.0001 (0.02%)

Pre-market: Nov 13, 2026, 4:01 AM EST

Genenta Science Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Quarter	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023
Period Ending	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Sep '24 Sep 30, 2024	Jun '24 Jun 30, 2024	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Sep '23 Sep 30, 2023
Selling, General & Admin	3.9	4.15	4.4	4.68	4.95	4.9	4.86	5.06	5.26	5.66
Research & Development	2.7	3.46	4.23	4.52	4.81	4.7	4.59	5.53	6.47	7.05
Operating Expenses	6.6	7.62	8.63	9.2	9.76	9.61	9.45	10.59	11.73	12.71
Operating Income	-6.6	-7.62	-8.63	-9.2	-9.76	-9.61	-9.45	-10.59	-11.73	-12.71
Interest & Investment Income	0.62	0.62	0.09	0.08	0.61	0.44	0.26	0.29	0.31	0.26
Currency Exchange Gain (Loss)	-0.55	-0.53	-0.52	-0.14	0.24	0.16	0.09	-0.06	-0.22	0.05
Other Non Operating Income (Expenses)	-	-0.09	0.36	0.44	-	0.09	0.18	0.09	-0	0.02
EBT Excluding Unusual Items	-6.53	-7.62	-8.7	-8.81	-8.91	-8.92	-8.92	-10.29	-11.65	-12.39
Pretax Income	-6.53	-7.62	-8.7	-8.81	-8.91	-8.92	-8.92	-10.29	-11.65	-12.39
Net Income	-6.53	-7.62	-8.7	-8.81	-8.91	-8.92	-8.92	-10.29	-11.65	-12.39
Net Income to Common	-6.53	-7.62	-8.7	-8.81	-8.91	-8.92	-8.92	-10.29	-11.65	-12.39
Net Income Growth (YoY)	-	-	-	-	-	-	-	-	-	-
Shares Outstanding (Basic)	20	19	19	18	18	18	18	18	18	18
Shares Outstanding (Diluted)	20	19	19	18	18	18	18	18	18	18
Shares Change (YoY)	7.86%	4.74%	1.60%	0.96%	0.31%	0.21%	0.11%	0.06%	-	-
EPS (Basic)	-0.33	-0.40	-0.47	-0.48	-0.49	-0.49	-0.49	-0.56	-0.64	-0.68
EPS (Diluted)	-0.33	-0.40	-0.47	-0.48	-0.49	-0.49	-0.49	-0.56	-0.64	-0.68
EPS Growth (YoY)	-	-	-	-	-	-	-	-	-	-

Additional Metrics

Fiscal Quarter	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023
Period Ending	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Sep '24 Sep 30, 2024	Jun '24 Jun 30, 2024	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Sep '23 Sep 30, 2023
Free Cash Flow	-6.88	-8.29	-9.71	-7.98	-6.24	-5.97	-5.69	-8.45	-11.22	-11.84
Free Cash Flow Per Share	-0.35	-0.43	-0.52	-0.43	-0.34	-0.33	-0.31	-0.46	-0.62	-0.65
EBITDA	-6.58	-7.58	-8.59	-9.16	-9.72	-9.56	-9.41	-10.55	-11.69	-12.68
D&A For EBITDA	0.03	0.03	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.03
EBIT	-6.6	-7.62	-8.63	-9.2	-9.76	-9.61	-9.45	-10.59	-11.73	-12.71

SEC Filings: 10-K · 10-Q